Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and CKD (AMBER): Results in the Prespecified Subgroup with Diabetes

Simple item page
dc.contributor.authorAgarwal, Rajiv
dc.contributor.authorRossignol, Patrick
dc.contributor.authorMayo, Martha R.
dc.contributor.authorConrad, Ansgar
dc.contributor.authorArthur, Susan
dc.contributor.authorWilliams, Bryan
dc.contributor.authorWhite, William B.
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2023-08-28T12:15:20Z
dc.date.available2023-08-28T12:15:20Z
dc.date.issued2021
dc.identifier.citationAgarwal R, Rossignol P, Mayo MR, et al. Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and CKD (AMBER): Results in the Prespecified Subgroup with Diabetes. Clin J Am Soc Nephrol. 2021;16(9):1407-1409. doi:10.2215/CJN.02890221
dc.identifier.urihttps://hdl.handle.net/1805/35171
dc.language.isoen_US
dc.publisherWolters Kluwer
dc.relation.isversionof10.2215/CJN.02890221
dc.relation.journalClinical Journal of the American Society of Nephrology
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectChronic renal insufficiency
dc.subjectDiabetes
dc.subjectHyperkalemia
dc.subjectHypertension
dc.subjectPatiromer
dc.subjectPolymers
dc.subjectResistant hypertension
dc.subjectSpironolactone
dc.titlePatiromer to Enable Spironolactone in Patients with Resistant Hypertension and CKD (AMBER): Results in the Prespecified Subgroup with Diabetes
dc.typeArticle
ul.alternative.fulltexthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729584/
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Patiromer to Enable Spironolactone in Patients with Resistant Hypertension.pdf
Size:
2.06 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Medicine Works